Ave Maria Biotech

Ave Maria Biotech AI-powered airborne pathogen detection systems for healthcare, senior living, public spaces, agriculture, and critical infrastructure. Real-time monitoring.

Rapid alerts. Better preparedness.

EBOLA CRISIS: MORE THAN 6,000 INFECTED IN CONGOThe Democratic Republic of the Congo is facing the largest Ebola outbreak...
08/31/2026

EBOLA CRISIS: MORE THAN 6,000 INFECTED IN CONGO

The Democratic Republic of the Congo is facing the largest Ebola outbreak in its history.

As of August 31, 6,041 people have been infected and 2,911 have died — nearly half of all confirmed patients.

The outbreak is caused by the rare Bundibugyo virus, for which there is currently no specifically approved vaccine or treatment. The virus has already spread across six provinces.

Behind every number is a person, a family and a community changed forever.

This tragedy reminds us of a painful truth: when a dangerous virus is discovered too late, every lost day gives it another opportunity to spread.

Early detection is not simply technology. It is time—and during an outbreak, time means lives.

Detect Early. Protect Sooner.

A simple nose clip may help reduce the risk of infection from the rare “brain-eating amoeba,” according to the New York ...
08/30/2026

A simple nose clip may help reduce the risk of infection from the rare “brain-eating amoeba,” according to the New York State Department of Health.

Naegleria fowleri can live in warm freshwater, including lakes, ponds, rivers, and hot springs. Infection can occur when contaminated water enters the nose, allowing the amoeba to travel to the brain and cause primary amebic meningoencephalitis—a rare but almost always fatal disease.

To reduce the risk:

• Use a nose clip or hold your nose when diving into freshwater.
• Keep your head above water in hot springs.
• For nasal or sinus rinsing, use only distilled, sterile, or previously boiled water.

The infection is not caused by swallowing contaminated water.

A Biological Threat to U.S. Agriculture Is Triggering an Expanding Federal ResponseThe FDA has issued its 14th Emergency...
08/28/2026

A Biological Threat to U.S. Agriculture Is Triggering an Expanding Federal Response

The FDA has issued its 14th Emergency Use Authorization against New World screwworm — a dangerous parasitic fly whose larvae can burrow into wounds and feed on the living tissue of livestock and other warm-blooded animals.

The latest authorization expands preventive options for certain cattle as the United States strengthens its defenses against the threat.

USDA is coordinating surveillance, trapping, animal inspections, sterile-fly production and rapid-response capabilities to prevent the parasite from becoming established.

This is more than an animal-health issue.

An emerging biological threat can quickly affect agriculture, food production, trade and the economy.

And the principle remains the same:

The earlier we detect a biological threat, the more time we have to contain it.

Detect. Protect. Save Lives.

Washington’s Drug-Pricing Push Is Moving Deeper Into BiotechThe White House is reportedly preparing a new round of drug-...
08/27/2026

Washington’s Drug-Pricing Push Is Moving Deeper Into Biotech

The White House is reportedly preparing a new round of drug-pricing agreements with midsize biotechnology companies.

Under the proposed approach, participating companies would provide discounts on certain outpatient medicines to state Medicaid programs, bringing U.S. pricing more closely in line with prices in other developed countries.

For patients, lower prices could mean better access to important medicines.

For biotech companies, however, the implications go much further.

Drug pricing affects revenue forecasts, company valuations, investment decisions, licensing strategies and ultimately how much capital is available to develop the next generation of therapies.

The challenge for U.S. healthcare policy is increasingly clear:

How do we make innovative medicines more affordable while preserving the incentives that make medical innovation possible?

That balance will matter enormously for the future of American biotechnology.

AI Is Changing the Biosecurity EquationArtificial intelligence is rapidly becoming one of the most powerful tools in bio...
08/26/2026

AI Is Changing the Biosecurity Equation

Artificial intelligence is rapidly becoming one of the most powerful tools in biology — capable of accelerating drug discovery, vaccine development and our understanding of disease.

But the same capabilities are creating a new biosecurity challenge.

Washington is increasingly confronting this dual reality: AI can potentially increase biological risk, but it can also become one of our strongest defenses against emerging threats.

The White House’s Genesis Mission calls for AI to combine genomic, metagenomic, clinical and environmental signals to help detect and characterize unusual biological threats earlier and accelerate the development of countermeasures.

The race is no longer only about what AI can create.

It is also about how quickly we can detect, understand and respond to what comes next.

Detect early. Protect sooner.

When Biology Meets Artificial IntelligenceWeill Cornell Medicine has created a new Department of Systems and Computation...
08/25/2026

When Biology Meets Artificial Intelligence

Weill Cornell Medicine has created a new Department of Systems and Computational Biomedicine, bringing together advanced genomics, molecular profiling, large-scale biological data and artificial intelligence.

Dr. Dan Landau, a cancer researcher and geneticist known for work in single-cell technologies and AI-powered liquid biopsy, will serve as its inaugural chair.

This reflects a much larger transformation happening in medicine: biology is increasingly becoming an information science.

The convergence of AI, genomics, sensors and clinical data has the potential to help us understand disease earlier, improve precision medicine and accelerate the next generation of diagnostics.

The more biological signals we can detect — and the faster we can understand them — the better we can protect human health.

COVID-19 Is Rising Across Nearly the Entire United StatesCDC modeling estimates that COVID-19 infections are growing or ...
08/24/2026

COVID-19 Is Rising Across Nearly the Entire United States

CDC modeling estimates that COVID-19 infections are growing or likely growing in 47 states, with no states currently classified as declining.

At the same time, the overall level of respiratory illness requiring medical care remains very low nationally.

This is where environmental surveillance becomes especially important.

Wastewater monitoring can detect changes in community transmission — including infections in people who never seek medical care or take a clinical test — and can provide an earlier signal before increases become visible in hospital data.

For airborne infectious threats, seeing the signal early means having more time to respond.

Detect early. Protect sooner.

Type 2 Diabetes Is Rising Alarmingly Among Young AmericansNew U.S. research shows a dramatic shift in a disease once ass...
08/24/2026

Type 2 Diabetes Is Rising Alarmingly Among Young Americans

New U.S. research shows a dramatic shift in a disease once associated primarily with middle and older age.

In Colorado, the rate of newly diagnosed type 2 diabetes among people under 20 has increased nearly tenfold since 2002, according to research being presented at the European Association for the Study of Diabetes Annual Meeting.

The findings are particularly concerning because youth-onset type 2 diabetes can progress aggressively and lead to serious complications at a younger age. The American Diabetes Association also reports that type 2 diabetes among children and adolescents has continued to increase over the past two decades.

This is more than a statistic. It is a warning about the growing burden of chronic disease on the next generation — and another reminder of the importance of prevention, screening and early diagnosis.

Early Detection. Stronger Protection.

DoD biothreat diagnostic shows reduced sensitivity to current Ebola strainFDA’s device database was updated regarding th...
08/23/2026

DoD biothreat diagnostic shows reduced sensitivity to current Ebola strain

FDA’s device database was updated regarding the FilmArray NGDS Warrior Panel, a molecular diagnostic system used in designated U.S. Department of Defense laboratories. Preliminary testing found a potential reduction in sensitivity to the 2026 Bundibugyo Ebola outbreak strain, creating a risk that some samples could return an “Orthoebolavirus spp. Not Detected” result.

The manufacturer has issued updated instructions and laboratory actions. The system is specifically designed to identify high-consequence biological-threat agents, including Ebola and Marburg viruses.

DARPA Is Moving Biological Sensing From the Lab to the FieldDARPA’s new Convergence program is focused on developing dep...
08/21/2026

DARPA Is Moving Biological Sensing From the Lab to the Field

DARPA’s new Convergence program is focused on developing deployable environmental biosensors that can operate in real-world defense environments — including technologies designed for remote or standoff detection.

The goal is bigger than creating a single sensor. DARPA wants an open-architecture platform that can make it faster to design, test, build and deploy new biosensors as new threats emerge.

That shift matters.

The future of biosecurity will increasingly depend on our ability to detect threats where they occur — not only after samples reach a laboratory.

Detect earlier. Understand faster. Protect better.

Address

5050 Avenue Maria Blwd Ave Maria
Naples, FL
34142

Website

Alerts

Be the first to know and let us send you an email when Ave Maria Biotech posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Ave Maria Biotech:

Shortcuts

Share

Category